Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
45.28
-0.60 (-1.31%)
May 21, 2026, 12:34 PM EDT - Market open
Tempus AI Employees
Tempus AI had 3,800 employees as of December 31, 2025. The number of employees increased by 1,400 or 58.33% compared to the previous year.
Employees
3,800
Change (1Y)
1,400
Growth (1Y)
58.33%
Revenue / Employee
$358,992
Profits / Employee
-$79,713
Market Cap
8.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3,800 | 1,400 | 58.33% |
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BrightSpring Health Services | 23,500 |
| Veeva Systems | 7,928 |
| Teladoc Health | 5,600 |
| Omnicell | 3,525 |
| HealthEquity | 2,814 |
| Waystar Holding | 1,700 |
| Privia Health Group | 1,226 |
| 10x Genomics | 1,178 |
TEM News
- 3 hours ago - Tempus AI announces clinical launch of ArteraAI Prostate Test - TheFly
- 4 hours ago - Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use - Business Wire
- 7 days ago - Tempus AI announces strategic collaboration with Bristol Myers - TheFly
- 7 days ago - Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience - Business Wire
- 9 days ago - Cathie Wood’s ARK Investment buys 163K shares of Tempus AI today - TheFly
- 10 days ago - Tempus AI price target lowered to $64 from $95 at H.C. Wainwright - TheFly
- 10 days ago - Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution” - Business Wire
- 11 days ago - Tempus AI price target lowered to $80 from $90 at BTIG - TheFly